News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
R&D Costs Push Merck KGaA’s Profit Down 48 Percent
July 27, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AFP -- The German chemical and pharmaceutical group Merck KGaA said Friday that its second quarter net profit had shed almost 48 percent owing to research and development costs.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
CSL Trims Research and Development Unit
July 8, 2025
·
152 min read
·
BioSpace Editorial Staff
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
·
3 min read
·
Annalee Armstrong
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
·
1 min read
·
Heather McKenzie
